Which are the causes of Fibromuscular dysplasia?

The exact cause of fibromuscular dysplasia remains unknown, though it is widely considered a complex, multifactorial condition involving a combination of genetic predisposition and potential hormonal or environmental triggers. Rather than a single gene mutation, fibromuscular dysplasia is likely influenced by a constellation of subtle genetic variants that affect the development and structure of arterial walls.

What is the underlying pathophysiology of fibromuscular dysplasia?

Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory disease that causes abnormal cell growth in the walls of medium-sized arteries. Imagine the artery wall as a multi-layered garden hose; in fibromuscular dysplasia, these layers—specifically the intima, media, or adventitia—undergo disorganized thickening. This structural change results in the characteristic "string-of-beads" appearance often seen on imaging. Because the condition is not caused by traditional plaque buildup (atherosclerosis) or vessel inflammation (vasculitis), it is classified as a distinct idiopathic arteriopathy.

Is fibromuscular dysplasia a hereditary condition?

Current clinical research suggests that fibromuscular dysplasia has a genetic component, but it does not follow simple Mendelian inheritance patterns (like cystic fibrosis). Approximately 7% to 10% of patients report a family history of the disease. Recent genome-wide association studies (GWAS) have identified a strong association with the PHACTR1 gene, which is also linked to other vascular conditions like spontaneous coronary artery dissection (SCAD). While this is a significant discovery, having a genetic predisposition does not guarantee that an individual will develop fibromuscular dysplasia.

What are the known risk factors for fibromuscular dysplasia?

Distinguishing between "causes" and "risk factors" is vital: a cause is the biological origin, while a risk factor is a correlation that increases the likelihood of the disease. Clinical data from the 132 members of the fibromuscular dysplasia community on DiseaseMaps.org and global registries highlight several key risk factors:

• Biological Sex: Over 90% of identified patients are female, suggesting that hormonal factors—specifically estrogen—may play a role in the development or progression of the disease.


• Smoking History: Tobacco use is consistently identified as a risk factor that may worsen the severity of arterial damage and increase the risk of disease progression.


• Age of Onset: While it can occur at any age, the condition is most commonly diagnosed in individuals between the ages of 40 and 60.


• Connective Tissue Disorders: There is a documented association between fibromuscular dysplasia and other vascular abnormalities, such as arterial tortuosity and aneurysms.

What does current research say about the etiology?

Medical researchers are currently investigating whether mechanical stress on arterial walls, combined with genetic susceptibility, triggers the abnormal cellular growth seen in fibromuscular dysplasia. Ongoing studies are focused on whether hormonal fluctuations or environmental "second hits" activate the pathways responsible for medial fibroplasia. Because the disease is rare, international registries are essential for pooling data to better understand why this condition affects specific arterial beds, such as the renal or carotid arteries, more frequently than others.

Next steps

• Consult a vascular specialist or a cardiologist with specific expertise in fibromuscular dysplasia to manage your vascular health.


• Request a comprehensive screening if you have a first-degree relative diagnosed with the condition or if you have unexplained hypertension or pulsatile tinnitus.


• Join the fibromuscular dysplasia community on DiseaseMaps.org to connect with others who are managing the same diagnosis and to stay updated on patient-led research initiatives.


• Avoid smoking, as it is a major modifiable risk factor that can exacerbate vascular wall stress.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fibromuscular Dysplasia.


• Orphanet: Fibromuscular Dysplasia (ORPHA:333).


• The US Registry for Fibromuscular Dysplasia (FMD Registry).


• OMIM (Online Mendelian Inheritance in Man): Fibromuscular Dysplasia (Entry #135580).